Home Company Services Upcoming Events Links Intern & Extern Programs News Contact Us

Moore and Company Update on EVH1 (Rhino) Outbreak in Saskatchewan - March of 2008



At this time the facts on this situation are as follows:



  • There has been confirmed cases of the neurologic form of EVH1 commonly known as Rhino in a stable close to Saskatoon and consequently some of those animals were taken to the teaching hospital at the Western College of Veterinary Medicine in that city.
  • There has been one horse die from this outbreak and another that is yet to be verified.
  • There have been up to 6 horses that have shown some neurologic signs with most of them stable or recovered.
  • There have been biosecurity steps taken at both locations to minimize the risk of spreading the infections. These are still in place until all horses stop shedding the virus.
  • As of April 7th, 2008 there have been no further confirmed or suspected cases within the last week.
  • There is no known link between this outbreak and the well publicized cases in Florida and California last year.




  • Our opinion on this, given the above information and our experience is:


  • Neurologic outbreaks of Rhino is and uncommon but regular occurring event within North America including Alberta for many years.
  • Luckily the outbreaks seem to be self limiting or they are able to be contained using good biosecurity methods.
  • The “new” “mutant” strain may the same strain that has caused these outbreaks over the years. This is a very recent theory and is being debated within academic circles.
  • Therefore, it is our opinion, given the knowledge available to us as of April 8, 2008 that the risk of contracting the neurologic form of this disease has changed very little from one month ago or one year ago.
  • Although the vaccine for this disease has not been shown to be helpful against the neurologic strain of the disease it may decrease the respiratory form of the disease and does lower the shedding time of the virus which would be helpful in controlling and respiratory or neurologic spread.




  • We have posted general information on this virus for your reading. It is important to read it so that you are generally knowledgeable on the topic. We will be monitoring this situation closely and will update this discussion paper if there are any significant changes.


    For additional information, please read or download this PDF file.


    Dr. Chris Berezowski
    DVM, DACT

    Equine Embryo Transfer

    What is Embryo Transfer (ET)?
    Embryo transfer is a reproductive technique that involves the collection of an embryo from a donor mare when the embryo is seven to eight days old. The embryo is then transferred into a recipient (surrogate) mare where a pregnancy can be established and carried to term.

    What are the benefits of embryo transfer? One of the main benefits of embryo transfer is that it allows performance mares to have a foal while still remaining in training/competition. Depending on the breed registry, multiple foals from a single mare in a season is possible. Mares that are unable to carry a pregnancy on their own due to physical or reproductive abnormalities can benefit as well. Embryo transfer can maximize the number of foals produced from genetically superior mares during their reproductive lifetime.

    How is Embryo Transfer performed? Embryo transfer involves the use of a donor and recipient mares who must be synchronized in their estrous (heat) cycles. Ideally, three recipient mares are needed for every donor mare. This ensures that one of the recipient mares will match the donor mares stage of the heat cycle. Both mares should be healthy, reproductively sound and cycling regularly. The donor mare is bred normally (AI, live cover) with special attention given to the time of ovulation and to ensure an excellent uterine environment. Seven or eight days after the donor mare has ovulated her uterus is flushed to recover the embryo. Several liters of flush media are warmed and infused into the uterus through a catheter. The uterus is flushed three or four times and drained through a filtered collection bottle. The collected embryo is washed to remove any contaminants and evaluated for viability based on the size, grade, morphology and developmental stage.

    The second stage involves transferring the embryo to the recipient mare. It is important that the recipient mare has ovulated no more than one day before or two days after the donor mare. The embryo is placed in an insemination gun and transferred into the uterus aided by rectal palpation. The initial pregnancy exam of the recipient mare will be conducted 4 days after the transfer. What makes a good recipient mare?

    An ideal recipient mare should be less then 9 years old, be of good physical/reproductive health and temperament. Moore and Company will have a herd of high quality recipient mares available for your donor mare’s embryo or you can provide your own suitable recipient mare.

    What are the success rates? To maximize the success of embryo transfer it is important to use high quality semen from fertile stallions. If the donor mare is pregnant, the embryo will be recovered in over 95% of cases. Once an embryo is recovered, the transfer success rate is dependent on the quality of the embryo. High quality embryos will result in pregnancy in 70 to 80% of cases. Donor mares can also be flushed at a distant veterinary facility with the embryo then shipped and transferred into one of our recipient mares with only a slight reduction in pregnancy rates.

    Embryo transfer is not a viable option for all mares and we would be happy to discuss the best breeding options for your mare. If you do decide to use this reproductive method, Moore and Company would be happy to assist you in achieving your goal.

    2006 Embryo Transfer Results
    We are proud to report that a pregnancy resulted from 84.6% of the embryos transferred in 2006!

    Spring 2006
    News Release

    Moore & Company opens new Equine Reproduction Center

    Moore & Company Veterinary Services is proud to introduce a new Equine Reproduction Center. Operating from the Canadiana Equestrian Center, the Repro Center offers a full range of services under the leadership of Dr. Chris Belan and Dr. Chris Berezowski.

    Dr. Belan is a twenty eight year veteran of both equine and bovine reproduction. Over the last ten years, Dr Belan has inseminated many mares with both frozen and fresh semen, with good success rates. He has worked closely with breeding stations doing semen collection and transporting. Dr Belan’s expertise, gained from working closely with experts in the field of theriogenology, has made him one of Moore & Company’s most requested veterinarians.

    Dr. Berezowski joined Moore & Co. upon completion of a theriogenology residency at Texas A&M University. He is a Diplomate of the American College of Threiogenologists. With a dedicated interest in equine reproduction, Dr. Berezowski has particular skill in embryo transfer, semen cryoprenservation, stallion/mare subfertility, high risk pregnancies and other assisted reproductive techniques. While at Texas A&M, he was part of the research team that was responsible for the birth of the first two cloned equines in North America.

    The Equine Reproduction Center offers artificial insemination with chilled and frozen semen, embryo transfer, stallion collection, semen freezing, fetal sexing mare and stallion breeding soundness evaluations and maintenance of a recipient herd.

    For more information, contact Moore & Company at (403) 226 – 2585